Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06065332 · ClinicalTrials.gov registry record · NA
Post-Procedural Biotech Cellulose Mask
A NA study, sponsored by Siperstein Dermatology.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT06065332 is a NA study that has completed, run by Siperstein Dermatology. The registered enrollment target is 15 participants.
The verdict
NCT06065332, a NA study, has completed, sponsored by Siperstein Dermatology.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Background: There are many post-procedural treatments touted to improve comfort and decrease downtime, but very few prospective randomized studies. Aims: To analyze the safety and efficacy of a post-procedural biotech cellulose mask Patients/Method: Fifteen patients undergoing either a microneedling with radiofrequency (n=5), non-ablative fractional (n=5), or full erbium;YAG resurfacing (n=5) treatment were randomized to receive a Velez biotech cellulose mask on one side of the face for 30 minutes after the procedure and for two hours a day until healed. Canfield Visia photos and thermal photographs were taken 30 minutes after the procedure and daily until healed. The investigator and blind evaluators reviewed the photos and subjects answered daily questionnaires.
Interventions
- OTHER Velez Intense Hydration Mask® (biotech cellulose face mask)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06065332
The ClinicalTrials.gov registry entry for NCT06065332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Siperstein Dermatology, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Velez Intense Hydration Mask® (biotech cellulose face mask) is the first listed.
NCT06065332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06065332 about?
NCT06065332 is a clinical study titled "Post-Procedural Biotech Cellulose Mask". Background: There are many post-procedural treatments touted to improve comfort and decrease downtime, but very few prospective randomized studies. Aims: To analyze the safety and efficacy of a post-procedural biotech cellulose mask Patients/Method: Fifteen patients undergoing either a microneedlin...
What is the current status of trial NCT06065332?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-11-07. Estimated completion is 2023-03-02.
What interventions are being tested in trial NCT06065332?
The interventions under investigation include: Velez Intense Hydration Mask® (biotech cellulose face mask) (OTHER).
Who is sponsoring clinical trial NCT06065332?
This trial is sponsored by Siperstein Dermatology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.